BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 10351471)

  • 1. Cost-effectiveness analysis of humanitarian relief interventions: visceral leishmaniasis treatment in the Sudan.
    Griekspoor A; Sondorp E; Vos T
    Health Policy Plan; 1999 Mar; 14(1):70-6. PubMed ID: 10351471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Royal Society of Tropical Medicine and Hygiene joint meeting with Médecins Sans Frontières at Manson House, London, 20 March 2003: field research in humanitarian medical programmes. Médecins Sans Frontières interventions against kala-azar in the Sudan, 1989-2003.
    Ritmeijer K; Davidson RN
    Trans R Soc Trop Med Hyg; 2003; 97(6):609-13. PubMed ID: 16134257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: course and impact from 1984 to 1994.
    Seaman J; Mercer AJ; Sondorp E
    Int J Epidemiol; 1996 Aug; 25(4):862-71. PubMed ID: 8921468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumonia Prevention during a Humanitarian Emergency: Cost-effectiveness of Haemophilus Influenzae Type B Conjugate Vaccine and Pneumococcal Conjugate Vaccine in Somalia.
    Gargano LM; Hajjeh R; Cookson ST
    Prehosp Disaster Med; 2015 Aug; 30(4):402-11. PubMed ID: 26061190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breastfeeding promotion and priority setting in health.
    Horton S; Sanghvi T; Phillips M; Fiedler J; Perez-Escamilla R; Lutter C; Rivera A; Segall-Correa AM
    Health Policy Plan; 1996 Jun; 11(2):156-68. PubMed ID: 10158457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sudan, through the back door].
    Veeken H
    Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1781-5. PubMed ID: 9856145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
    Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
    Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of Humanitarian Pediatric Cardiac Surgery Programs in Low- and Middle-Income Countries.
    Cardarelli M; Vaikunth S; Mills K; DiSessa T; Molloy F; Sauter E; Bowtell K; Rivera R; Shin AY; Novick W
    JAMA Netw Open; 2018 Nov; 1(7):e184707. PubMed ID: 30646368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the use of economic evaluations in health-related humanitarian programmes in low- and middle-income countries: a systematic review.
    Makhani LA; Moran V; Sadique Z; Singh NS; Revill P; Roberts B
    Health Policy Plan; 2020 Mar; 35(2):210-218. PubMed ID: 31697373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of visceral leishmaniasis during the conflict in South Sudan and the consequences for East African countries.
    Al-Salem W; Herricks JR; Hotez PJ
    Parasit Vectors; 2016 Aug; 9(1):460. PubMed ID: 27549162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the cost-effectiveness of interventions within a humanitarian organisation.
    Puett C
    Disasters; 2019 Jul; 43(3):575-590. PubMed ID: 31012136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of violence against women and girls: A cost-effectiveness study across 6 low- and middle-income countries.
    Ferrari G; Torres-Rueda S; Chirwa E; Gibbs A; Orangi S; Barasa E; Tawiah T; Dwommoh Prah RK; Hitimana R; Daviaud E; Kapapa E; Dunkle K; Heise L; Stern E; Chatterji S; Omondi B; Ogum Alangea D; Karmaliani R; Maqbool Ahmed Khuwaja H; Jewkes R; Watts C; Vassall A
    PLoS Med; 2022 Mar; 19(3):e1003827. PubMed ID: 35324910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India.
    Olliaro P; Darley S; Laxminarayan R; Sundar S
    Trop Med Int Health; 2009 Aug; 14(8):918-25. PubMed ID: 19563434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normalising the crisis in Africa.
    Bradbury M
    Disasters; 1998 Dec; 22(4):328-38. PubMed ID: 9874898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of Pediatric Visceral Leishmaniasis Care in Morocco.
    Tachfouti N; Najdi A; Alonso S; Sicuri E; Laamrani El Idrissi A; Nejjari C; Picado A
    PLoS One; 2016; 11(6):e0155482. PubMed ID: 27257808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania.
    Sweat M; Gregorich S; Sangiwa G; Furlonge C; Balmer D; Kamenga C; Grinstead O; Coates T
    Lancet; 2000 Jul; 356(9224):113-21. PubMed ID: 10963247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic burden of visceral leishmaniasis in Sudan: an assessment of provider and household costs.
    Meheus F; Abuzaid AA; Baltussen R; Younis BM; Balasegaram M; Khalil EAG; Boelaert M; Musa AM
    Am J Trop Med Hyg; 2013 Dec; 89(6):1146-1153. PubMed ID: 24189368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to treatment for visceral leishmaniasis in hyperendemic areas: India, Bangladesh, Nepal, Brazil and Sudan.
    Thornton SJ; Wasan KM; Piecuch A; Lynd LL; Wasan EK
    Drug Dev Ind Pharm; 2010 Nov; 36(11):1312-9. PubMed ID: 20545513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmaniasis in Sudan. Visceral leishmaniasis.
    Zijlstra EE; el-Hassan AM
    Trans R Soc Trop Med Hyg; 2001 Apr; 95 Suppl 1():S27-58. PubMed ID: 11370250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.